Table 4. Variables at beginning of treatment (T₀).

Variable

Age’

Gender”

DCMax §

DP1Max §

DP2Max §

DM1Max §

DM2Max§

DCMd§

DP1Md§

DP2Md§

DM1Md§

DM2Md§

IMPA˜

MAng˜

ArchD§

SL

19.91 ± 11.34

36/15

33.2 ± 2.08

39.36 ± 2.97

44.29 ± 2.98

49.49 ± 2.68

54.85 ± 3.24

25.66 ± 2.60

32.42 ± 2.63

37.99 ± 2.80

43.32 ± 2.48

48.38 ± 2.78

91.88 ± 7.03

95.60 ± 5.45

22.41 ± 1.95

CL

16.38 ± 9.86

34/21

33.54 ± 2.40

40.18 ± 2.07

45.06 ± 2.59

50.32 ± 2.68

55.86 ± 2.78

25.15 ± 1.68

32.98 ± 2.31

38.62 ± 2.58

43.59 ± 2.48

49.14 ± 2.79

92.40 ± 5.31

94.19 ± 5.72

21.40 ± 3.12

CT

24.05 ± 2.15

12/8

33.13 ± 1.90

39.82 ± 1.88

45.29 ± 2.05

50.16 ± 2.68

55.79 ± 2.44

24.72 ± 1.21

32.64 ± 1.66

38.17 ± 2.12

44.30 ± 1.90

49.80 ± 1.82

94.39 ± 6.98

93.78 ± 4.11

21.39 ± 1.88

p-value

0.0134*

0.5584†

0.6540*

0.2347*

0.2480*

0.2521*

0.2971*

0.1915*

0.4801*

0.4676*

0.3235*

0.1287*

0.3686*

0.3606*

0.1447*

SL = Self-ligating group; CL = conventional group; CT = control group. *ANOVA 95%; † Pearson’s chi-square test. ’ Years. ” Female/Male. § Millimeters (mm). ˜ Angle (degrees).